{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:29:09Z","timestamp":1762100949835},"reference-count":17,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1016\/j.diagmicrobio.2009.06.022","type":"journal-article","created":{"date-parts":[[2009,10,13]],"date-time":"2009-10-13T09:16:06Z","timestamp":1255425366000},"page":"331-334","source":"Crossref","is-referenced-by-count":34,"title":["Antipseudomonal activity of piperacillin\/tazobactam: more than a decade of experience from the SENTRY Antimicrobial Surveillance Program (1997\u20132007)"],"prefix":"10.1016","volume":"65","author":[{"given":"Ronald N.","family":"Jones","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew G.","family":"Stilwell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul R.","family":"Rhomberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helio S.","family":"Sader","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2009.06.022_bib1","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/jac\/dkg270","article-title":"Increasing prevalence of antimicrobial resistance among Pseudomonas aeruginosa isolates in Latin American medical centres: 5 year report of the SENTRY Antimicrobial Surveillance Program (1997\u20132001)","volume":"52","author":"Andrade","year":"2003","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.diagmicrobio.2009.06.022_bib2","doi-asserted-by":"crossref","first-page":"506","DOI":"10.2165\/00003495-199447030-00008","article-title":"Piperacillin\/tazobactam. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential","volume":"47","author":"Bryson","year":"1994","journal-title":"Drugs"},{"key":"10.1016\/j.diagmicrobio.2009.06.022_bib3","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1128\/AAC.01011-08","article-title":"Carbapenem resistance among Pseudomonas aeruginosa strains from India: evidence for nationwide endemicity of multiple metallo-beta-lactamase clones (VIM-2, -5, -6, and -11 and the newly characterized VIM-18)","volume":"53","author":"Castanheira","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2009.06.022_bib4","series-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2009"},{"key":"10.1016\/j.diagmicrobio.2009.06.022_bib5","series-title":"Performance standards for antimicrobial susceptibility testing: 19th information supplement (M100-S19)","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2009"},{"key":"10.1016\/j.diagmicrobio.2009.06.022_bib6","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/jac\/dkp201","article-title":"Update on the treatment of Pseudomonas aeruginosa pneumonia","volume":"64","author":"El Solh","year":"2009","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.diagmicrobio.2009.06.022_bib7","author":"EUCAST"},{"key":"10.1016\/j.diagmicrobio.2009.06.022_bib8","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.diagmicrobio.2007.12.010","article-title":"In vitro potency evaluations of various piperacillin\/tazobactam generic products compared with the contemporary branded (Zosyn\u00ae, Wyeth) formulation","volume":"61","author":"Jones","year":"2008","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2009.06.022_bib9","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0924-8579(03)00245-0","article-title":"Contemporary in vitro spectrum of activity summary for antimicrobial agents tested against 18569 strains non-fermentative Gram-negative bacilli isolated in the SENTRY Antimicrobial Surveillance Program (1997\u20132001)","volume":"22","author":"Jones","year":"2003","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"Suppl 1","key":"10.1016\/j.diagmicrobio.2009.06.022_bib10","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1469-0691.2007.01856.x","article-title":"Breakpoints for intravenously used cephalosporins in Enterobacteriaceae\u2014EUCAST and CLSI breakpoints","volume":"14","author":"Kahlmeter","year":"2008","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.diagmicrobio.2009.06.022_bib11","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/jac\/47.3.247","article-title":"Of Pseudomonas, porins, pumps and carbapenems","volume":"47","author":"Livermore","year":"2001","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.diagmicrobio.2009.06.022_bib12","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1086\/510590","article-title":"Piperacillin\u2013tazobactam for Pseudomonas aeruginosa infection: clinical implications of an extended-infusion dosing strategy","volume":"44","author":"Lodise","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2009.06.022_bib13","series-title":"Zosyn(R)","author":"Package Insert","year":"2007"},{"key":"10.1016\/j.diagmicrobio.2009.06.022_bib14","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.diagmicrobio.2009.03.002","article-title":"Outcomes of extended infusion piperacillin\/tazobactam for documented Gram-negative infections","volume":"64","author":"Patel","year":"2009","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2009.06.022_bib15","doi-asserted-by":"crossref","first-page":"805","DOI":"10.2165\/00003495-199957050-00017","article-title":"Piperacillin\/tazobactam: an updated review of its use in the treatment of bacterial infections","volume":"57","author":"Perry","year":"1999","journal-title":"Drugs"},{"key":"10.1016\/j.diagmicrobio.2009.06.022_bib16","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1097\/00003246-199905000-00020","article-title":"Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System","volume":"27","author":"Richards","year":"1999","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.diagmicrobio.2009.06.022_bib17","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/clinids\/22.1.107","article-title":"Piperacillin\/tazobactam: a critical review of the evolving clinical literature","volume":"22","author":"Sanders","year":"1996","journal-title":"Clin. Infect. Dis."}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889309002752?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889309002752?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,16]],"date-time":"2018-12-16T03:23:41Z","timestamp":1544930621000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889309002752"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["S0732889309002752"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2009.06.022","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]}}}